BIOLINERX     Print Page  Close Window

SEC filings
6-K
BIOLINERX LTD. filed this Form 6-K on 08/20/2015
Entire Document
 
7

 


BioLineRx Ltd.
CONDENSED CONSOLIDATED INTERIM CASH FLOW STATEMENTS
(UNAUDITED)

   
Six months ended June 30,
 
   
2014
   
2015
 
   
in USD thousands
 
             
CASH FLOWS - OPERATING ACTIVITIES
           
Comprehensive loss for the period
    (6,182 )     (9,121 )
Adjustments required to reflect net cash used in operating activities (see appendix below)
    (1,551 )     1,976  
Net cash used in operating activities
    (7,733 )     (7,145 )
                 
CASH FLOWS - INVESTING ACTIVITIES
               
Investments in short-term deposits
    (30,825 )     (39,184 )
Maturities of short-term deposits
    15,446       22,738  
Maturities of restricted deposits
    -       166  
Purchase of property and equipment
    (88 )     (1,586 )
Purchase of intangible assets
    (3 )     (7 )
Net cash used in investing activities
    (15,470 )     (17,873 )
                 
CASH FLOWS - FINANCING ACTIVITIES
               
Issuances of share capital, net
    22,612       28,645  
Net cash provided by financing activities
    22,612       28,645  
                 
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
    (591 )     3,627  
CASH AND CASH EQUIVALENTS – BEGINNING
OF PERIOD
    8,899       5,790  
EXCHANGE DIFFERENCES ON CASH AND CASH EQUIVALENTS
    116       (13 )
CASH AND CASH EQUIVALENTS - END OF PERIOD
    8,424       9,404